Scaling up/out: cost-effective and robust transitioning through the clinic to commercial manufacture

CELL AND GENE THERAPY INSIGHTS

Scaling up/out: cost-effective and robust transitioning through the clinic to commercial manufacture

September 2020
Scaling up/out: cost-effective and robust transitioning through the clinic to commercial manufacture
Download PDF

Foreword

Scaling up/out: cost-effective and robust transitioning through the clinic to commercial manufacture

Scaling up/out: cost-effective and robust transitioning through the clinic to commercial manufacture

Jan Thirkettle
29 September 2020
Read

Expert Insight

Scale-up vs scale-out: evaluating manufacturing scalability of CAR T cell therapy using process simulation tools

Scale-up vs scale-out: evaluating manufacturing scalability of CAR T cell therapy using process simulation tools

Apoorva Katragadda, Iftekhar Karimi, Xiaonan Wang
3 September 2020
Read

Innovator Insight

Scalable and efficient AAV production process with new Fibro chromatography technology

Scalable and efficient AAV production process with new Fibro chromatography technology

Laura Adamson-Small
30 September 2020
Read

Commentary

The power of small: success of small academic/healthcare units within the cell & gene therapy industry

The power of small: success of small academic/healthcare units within the cell & gene therapy industry

Benjamin Weil, Owen Bain
24 September 2020
Read
Small labels, big challenges: solutions for advanced therapy labeling

Small labels, big challenges: solutions for advanced therapy labeling

Christophe Suchet
21 September 2020
Read

Interview

Delivering cell and gene therapies: evolving logistics considerations

Delivering cell and gene therapies: evolving logistics considerations

Adrian Lee-Mohan, David Murphy
29 September 2020
Read
A necessary transition: why viral vector production for gene therapy needs to evolve

A necessary transition: why viral vector production for gene therapy needs to evolve

29 September 2020
Read
Driving NK cell therapy manufacture to commercial scale

Driving NK cell therapy manufacture to commercial scale

Leonard Sender
23 September 2020
Read

Podcast

Delivering cell and gene therapies: evolving logistics considerations - Podcast

Delivering cell and gene therapies: evolving logistics considerations - Podcast

Adrian Lee-Mohan, David Murphy
29 September 2020
Listen

Expert Roundtable Video

Expert Roundtable: getting a gene therapy product to market: pitfalls and how to prevent them

Expert Roundtable: getting a gene therapy product to market: pitfalls and how to prevent them

Hetal Brahmbhatt, Thomas Guarinoni, Elizabeth Simmons
22 September 2020
Watch

Expert Roundtable

Expert Roundtable: getting a gene therapy product to market: pitfalls and how to prevent them

Expert Roundtable: getting a gene therapy product to market: pitfalls and how to prevent them

Hetal Brahmbhatt, Thomas Guarinoni, Elizabeth Simmons
29 September 2020
Read

FastFacts

TESSA technology: a new paradigm in AAV manufacturing

TESSA technology: a new paradigm in AAV manufacturing

Ryan Cawood
1 October 2020
Read

Webinars

Scalable and efficient AAV production process with new Fibro chromatography technology

Scalable and efficient AAV production process with new Fibro chromatography technology

L Adamson-Small, M Lundgren, P Guterstam
30 July 2020
Watch
Size matters: ensuring donor pool sustainability and cell therapy supply chain success when scaling up and out

Size matters: ensuring donor pool sustainability and cell therapy supply chain success when scaling up and out

C Learn PhD, A Agarwal, R Hornung MBA MBCI CEM CBCP
6 August 2020
Watch
Realizing flexible automation – Closing gaps to meet industry needs

Realizing flexible automation – Closing gaps to meet industry needs

K Niss PhD, S Thompson PhD, M Lowdell PhD
12 August 2020
Watch
Get your assay in gear – removing analytical bottlenecks on the path to clinical readiness

Get your assay in gear – removing analytical bottlenecks on the path to clinical readiness

Ian Gaudet
8 September 2020
Watch
The multi-modal manufacturing movement - you don't need to know the future to be ready for it

The multi-modal manufacturing movement - you don't need to know the future to be ready for it

Peter Walters, Noel Maestre PE LEED AP
30 September 2020
Watch